This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Rafet Gunay Yavuz Sensoz Ilyas Kayacioglu Abdullah Kemal Tuygun Ahmet Yavuz Balci Ugur Kisa Ibrahim Yekeler Permission Requests Citing Articles Citing Articles via HighWire Google Scholar Articles by Gunay, R. Articles by Yekeler, I. PubMed PubMed Citation Articles by Gunay, R. Articles by Yekeler, I. Related Collections Related Article

Is the aortic valve pathology type different for early and late mortality in concomitant aortic valve replacement and coronary artery bypass surgery?

Department of Cardiovascular Surgery, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Center, Istanbul, Turkey

*Corresponding author. M.Akif Cad. Saklvadi Konutlar, Manolya-1 D: 9 Bahçelievler 34180 Istanbul, Turkey. Tel.: +90 212 5390344; fax: +90 216 4189649.

E-mail address: rafetgunay{at}hotmail.com (R. Gunay).

We assessed the effects of aortic valve pathology type on the long-term outcomes of patients who underwent concomitant aortic valve replacement (AVR) and coronary artery bypass grafting (CABG) surgery. We retrospectively reviewed 150 patients who underwent AVR-CABG at our institution between January 1997 and December 2006. We divided patients into aortic stenosis (AS), aortic regurgitation (AR), and mixed-type groups consisting of 98 (65.3%), 20 (13.3%) and 32 (21.3%) patients, respectively. The AS group had more female patients, a higher mean angina class, older mean patient age, increased history of previous myocardial infarction (MI), and smaller valve size compared to other groups. No significant differences were observed among groups in the operative mortality for five or ten-year survival rates. Significant early mortality risk factors included cross-clamp and cardiopulmonary bypass (CBP) time, number of blood transfusion units, chronic obstructive pulmonary disease (COPD), intra-aortic balloon pump (IABP), inotropic drugs, and pacemaker use. Significant late mortality risk factors included intensive care unit (ICU) stay, IABP, stroke, and dialysis. The aortic valve pathology type in patients undergoing concomitant AVR-CABG does not adversely affect survival.

Key Words: Coronary artery bypass grafting; Aortic valve replacement; Aortic valve pathology; Early and late mortality

Related Article

eComment: Re: Is the aortic valve pathology type different for early and late mortality in concomitant aortic valve replacement and coronary artery bypass surgery?

Leo A. Bockeria, Ivan I. Scopin, Sergey Yu. Kambarov, and Yuliya S. Dmitrieva
Interactive CardioVascular and Thoracic Surgery 2009 9: 634. [Full Text] [PDF]

This article has been cited by other articles:

				L. A. Bockeria, I. I. Scopin, S. Yu. Kambarov, and Y. S. Dmitrieva eComment: Re: Is the aortic valve pathology type different for early and late mortality in concomitant aortic valve replacement and coronary artery bypass surgery? Interactive CardioVascular and Thoracic Surgery, October 1, 2009; 9(4): 634 - 634. [Full Text] [PDF]

				R. Gunay eComment: Mechanical valve replacement in the elderly: does anticoagulation have benefit? Interactive CardioVascular and Thoracic Surgery, October 1, 2009; 9(4): 581 - 582. [Full Text] [PDF]